Stock listing

NASDAQ:ALIM Alimera Sciences Inc Stock

Follow Alimera Sciences Inc into a list and get an email when it puts out news.

Last close · NASDAQ:ALIM

$5.54 USD

Close on Sep 13, 2024 · No longer trades

Nov 15, 2019 to last close +16.6% · weekly closes, Nov 15, 2019 – Sep 13, 2024
Lowest – highest close
$1.35 – $11.35 USDSince Nov 15, 2019 · lowest Mar 22, 2023 · highest Mar 11, 2021

Delisted NASDAQ:ALIM no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:ALIM
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Alimera Sciences Inc on 6ix

Calls
10 calls with a replay · 10 with a transcript · latest May 14, 2024
Decks
23 decks · latest Jun 7, 2022

Events

CallWhenStatus
Alimera Sciences (ALIM) Q1 2024 Earnings CallTue, May 14, 2024 · 9:00 AM ETReplay
Alimera Sciences (ALIM) Q4 2023 Earnings CallThu, Mar 07, 2024 · 9:00 AM ETReplay
Alimera Sciences (ALIM) Q3 2023 Earnings CallThu, Oct 26, 2023 · 9:00 AM ETReplay
Alimera Sciences (ALIM) Q2 2023 Earnings CallThu, Aug 10, 2023 · 9:00 AM ETReplay
Alimera Sciences (ALIM) Q1 2023 Earnings CallThu, May 18, 2023 · 8:30 AM ETReplay
Alimera Sciences (ALIM) Q4 2022 Earnings CallFri, Mar 31, 2023 · 9:00 AM ETReplay
Alimera Sciences (ALIM) Q3 2022 Earnings CallMon, Nov 14, 2022 · 9:00 AM ETReplay
Alimera Sciences (ALIM) Q2 2022 Earnings CallWed, Jul 27, 2022 · 9:00 AM ETReplay
Alimera Sciences (ALIM) Q1 2022 Earnings CallMon, May 09, 2022 · 9:00 AM ETReplay
Alimera Sciences (ALIM) Q4 2021 Earnings CallThu, Feb 24, 2022 · 9:00 AM ETReplay

Open Events

Decks

DeckKindSlidesDate
Corporate Update (June 2022)Corporate update20 slidesJun 7, 2022
Q4 2018 Earnings PresentationEarnings13 slidesFeb 19, 2019
Q3 2018 Earnings PresentationEarnings10 slidesNov 6, 2018
Q2 2018 Earnings PresentationEarnings11 slidesJul 30, 2018
Q1 2018 Earnings PresentationEarnings13 slidesMay 3, 2018
Q3 2017 Earnings PresentationEarnings16 slidesNov 2, 2017
Q2 2017 Earnings PresentationEarnings12 slidesAug 3, 2017
Q1 2017 Earnings PresentationEarnings22 slidesMay 9, 2017
FY2016 Earnings PresentationEarnings13 slidesMar 1, 2017
Q3 2016 Earnings PresentationEarnings12 slidesNov 3, 2016
All 23 decks
DeckKindSlidesDate
Q2 2016 Earnings PresentationEarnings12 slidesAug 4, 2016
Cantor Fitzgerald's 2nd Annual Healthcare Conference 2016Conference20 slidesJul 12, 2016
Q1 2016 Earnings PresentationEarnings13 slidesMay 5, 2016
Investor Presentation (March 2016)Investor deck21 slidesMar 8, 2016
Q4 2015 Earnings PresentationEarnings15 slidesMar 3, 2016
UBS Healthcare Conference (May 2015)Conference28 slidesMay 18, 2015
Investor Day (March 2015)Investor day67 slidesMar 25, 2015
Investor Day (July 2012)Investor day54 slidesJul 18, 2012
Technical Presentation (August 2011)Technical20 slidesAug 25, 2011
Technical Presentation (May 2011)Technical15 slidesMay 5, 2011
Technical Presentation (May 2011)Technical31 slidesMay 3, 2011
Technical Presentation (February 2011)Technical25 slidesFeb 14, 2011
Technical Presentation (February 2011)Technical21 slidesFeb 3, 2011

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Russell Skibsted
Other companies: Processa Pharmaceuticals, Inc. (Chief Financial Officer · Since at least Jul 16, 2024); Aeolus Pharmaceuticals Inc (Chief Financial Officer · Since at least May 23, 2012); Rockwell Medical, Inc. (See Remarks · Sep 15, 2020 – Sep 9, 2022 · Past); Serina Therapeutics, Inc. (Chief Financial Officer · Nov 27, 2018 – Dec 31, 2018 · Past); Insight Molecular Diagnostics Inc. (Chief Financial Officer · Dec 30, 2015 – Dec 30, 2015 · Past); Lineage Cell Therapeutics, Inc. (Chief Financial Officer · Nov 16, 2015 – Dec 18, 2018 · Past)
Chief Financial Officer & SVP · Jan 9, 2023 – Nov 21, 2023 · Past
Garheng Kong
Other companies: Xeris Biopharma Holdings, Inc. (Director · Since at least Oct 5, 2021); Labcorp Holdings Inc. (Director · Since at least Feb 4, 2020); Venus Concept Inc (Director · Nov 7, 2019 – Mar 24, 2023 · Past); Strongbridge Biopharma plc (Director · May 15, 2019 – Oct 5, 2021 · Past)
Director · Jun 19, 2019 – Jan 4, 2023 · Past
Michael Kaseta
Other companies: Heron Therapeutics, Inc. (Director · Since at least Nov 4, 2024); Liquidia Corporation (CFO and COO · Since at least Nov 30, 2020); Aralez Pharmaceuticals Inc (Chief Financial Officer · Nov 30, 2017 – Mar 15, 2018 · Past)
Director · Mar 24, 2023 – Sep 16, 2024 · Past
Brian K Halak
Other companies: Dicerna Pharmaceuticals Inc (Director · Jan 29, 2014 – Nov 2, 2018 · Past)
Director · Jun 18, 2013 – Jan 4, 2023 · Past
Calvin W Roberts
Other companies: IVERIC bio Inc (Director · Jan 1, 2019 – Jul 11, 2023 · Past)
Director · Jun 18, 2013 – Jun 19, 2018 · Past
Erin Parsons
Other companies: Kiora Pharmaceuticals, Inc. (Director · Since at least Mar 3, 2023)
Director · Jan 4, 2023 – Sep 16, 2024 · Past
Todd Michael Wood
Other companies: Constellation Alpha Capital Corp (Chief Commercial Officer · Aug 29, 2019 – Jun 12, 2023 · Past)
President of U.S. Operations · Dec 11, 2023 – Sep 16, 2024 · Past
David HollandChief Marketing Officer & SVP · Nov 21, 2023 – Sep 16, 2024 · Past
Peter J Pizzo IIIDirector · Jun 14, 2012 – Sep 16, 2024 · Past
Philip AshmanPresident of Int'l Operations · Jan 4, 2016 – Sep 16, 2024 · Past
All 11 people
PersonSeat
Samer KabaChief Medical Officer · Apr 4, 2019 – Jan 7, 2021 · Past

Open People

Log in to ask 6ix AI your own questions about Alimera Sciences Inc.